RankingsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Income before tax

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥78.2B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Dec 31, 2024-4,662-56.35%
Dec 31, 2023-10,680-1090.72%
Dec 31, 20221,078+148.96%
Dec 31, 2021433-73.30%
Dec 31, 20201,622+203.75%
Dec 31, 2019534-107.37%
Dec 31, 2018-7,243+95.65%
Mar 31, 2018-3,702-129.66%
Mar 31, 201712,483-478.62%
Mar 31, 2016-3,297-353.42%
Mar 31, 20151,301+76.53%
Mar 31, 2014737-22.91%
Mar 31, 2013956-149.03%
Mar 31, 2012-1,950

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)